Literature DB >> 17990852

Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles.

Timo Laaksonen1, Hélder Santos, Henna Vihola, Jarno Salonen, Joakim Riikonen, Teemu Heikkilä, Leena Peltonen, Narendra Kumar, Dmitry Yu Murzin, Vesa-Pekka Lehto, Jouni Hirvonen.   

Abstract

In this work, it is shown that the common toxicity indicator, MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide), will fail to predict the toxicity of porous silicon (PSi) microparticles. This is due to the spontaneous redox reactions where the MTT is reduced and the PSi particle surfaces are oxidized simultaneously. MTT was shown to even react with thermally oxidized and carbonized forms of PSi particles, although the treatment did give an enhanced protection against the unwanted reactions as compared to as-anodized PSi particles. The observed levels of cellular viability with the MTT assay were much higher than expected in the presence of Caco-2 cells, even considering the spontaneous reduction of MTT at PSi surfaces. The results indicate that the redox reaction is further enhanced inside living cells. Thus, we recommend that MTT should not be used to test the cytotoxicity of drug formulations containing PSi microparticles. The study also shows that since PSi particles are capable of reducing the MTT, they will also be able to reduce other species as well. This should be taken into account when considering future applications for the porous silicon particles. The completely oxidized SiO2 particles (MCM-41 and SBA-15) were shown to work as expected with the MTT assay and showed no inherent oxidation/reduction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17990852     DOI: 10.1021/tx700326b

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  16 in total

1.  Sustained Release of a Monoclonal Antibody from Electrochemically Prepared Mesoporous Silicon Oxide.

Authors:  Jennifer S Andrew; Emily J Anglin; Elizabeth C Wu; Michelle Y Chen; Lingyun Cheng; William R Freeman; Michael J Sailor
Journal:  Adv Funct Mater       Date:  2010-09-08       Impact factor: 18.808

2.  Cisplatin-loaded porous Si microparticles capped by electroless deposition of platinum.

Authors:  Jennifer S Park; Joseph M Kinsella; Danielle D Jandial; Stephen B Howell; Michael J Sailor
Journal:  Small       Date:  2011-06-01       Impact factor: 13.281

3.  Evaluation of cell function upon nanovector internalization.

Authors:  Jonathan O Martinez; Alessandro Parodi; Xuewu Liu; Mikhail G Kolonin; Mauro Ferrari; Ennio Tasciotti
Journal:  Small       Date:  2012-11-20       Impact factor: 13.281

Review 4.  The practicality of mesoporous silica nanoparticles as drug delivery devices and progress toward this goal.

Authors:  Robert Roggers; Shrey Kanvinde; Suthida Boonsith; David Oupický
Journal:  AAPS PharmSciTech       Date:  2014-05-29       Impact factor: 3.246

5.  Real-time monitoring of sustained drug release using the optical properties of porous silicon photonic crystal particles.

Authors:  Elizabeth C Wu; Jennifer S Andrew; Lingyun Cheng; William R Freeman; Lindsey Pearson; Michael J Sailor
Journal:  Biomaterials       Date:  2010-11-30       Impact factor: 12.479

Review 6.  Biocompatibility assessment of Si-based nano- and micro-particles.

Authors:  Hamsa Jaganathan; Biana Godin
Journal:  Adv Drug Deliv Rev       Date:  2012-05-22       Impact factor: 15.470

7.  Nanofibrous materials affect the reaction of cytotoxicity assays.

Authors:  Rafał Podgórski; Michał Wojasiński; Tomasz Ciach
Journal:  Sci Rep       Date:  2022-05-31       Impact factor: 4.996

8.  Oxidation-triggered release of fluorescent molecules or drugs from mesoporous Si microparticles.

Authors:  Elizabeth C Wu; Ji-Ho Park; Jennifer Park; Ester Segal; Frédérique Cunin; Michael J Sailor
Journal:  ACS Nano       Date:  2008-11-25       Impact factor: 15.881

9.  Induction of functional changes of dendritic cells by silica nanoparticles.

Authors:  Kyeongah Kang; Jong-Seok Lim
Journal:  Immune Netw       Date:  2012-06-30       Impact factor: 6.303

10.  Biocompatibility of crystalline opal nanoparticles.

Authors:  Marlen Hernández-Ortiz; Laura S Acosta-Torres; Genoveva Hernández-Padrón; Alicia I Mendieta; Rodolfo Bernal; Catalina Cruz-Vázquez; Victor M Castaño
Journal:  Biomed Eng Online       Date:  2012-10-22       Impact factor: 2.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.